Pre-transplant and persistent post-transplant hyperparathyroidism and kidney transplant outcomes: a systematic review and meta-analysis
Clinical Kidney Journal · 01.07.2026 · 19 (7)
DOI: 10.1093/ckj/sfag205 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Kidney Journal, online erschienen am 15.06.2026. Verfasst von Daniele Vetrano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Science (DIMEC), Alma Mater Studiorum-University of Bologna, Bologna, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Hyperparathyroidism (HPT) is common in chronic kidney disease and may persist after kidney transplantation, but its prognostic significance remains uncertain because of heterogeneous definitions and variable timing of assessment.
Methods
We performed a systematic review and meta-analysis of observational studies in adult kidney transplant recipients (KTRs) in accordance with PRISMA 2020 (PROSPERO CRD420261293712). PubMed/MEDLINE and Embase were searched from inception to 9 February 2026. Exposures included pre- and post-transplant parathyroid hormone (PTH)/Persistent HPT assessed as categorical or continuous variables. Outcomes were all-cause mortality, overall graft failure, and death-censored graft failure. Random-effects models were applied, with Hartung–Knapp sensitivity analyses; risk of bias was assessed using QUIPS.
Results
23 studies were included in the systematic review, and 19 studies (26 266 KTRs) contributed to the meta-analyses (3 pre-transplant studies N = 12 819; 16 post-transplant studies N = 13 447). Pre-transplant HPT was not associated with all-cause mortality (HR 0.80) and showed an association with death-censored graft failure (DCGF) in the main analysis (HR 1.42) that lost statistical significance with Hartung–Knapp adjustment. By contrast, categorical Persistent HPT was associated with higher risks of all-cause mortality (HR 1.74), overall graft failure (HR 2.16), and DCGF (HR 1.92), with consistent Hartung–Knapp results. Phenotype-stratified analyses showed a gradient of graft failure risk from normocalcemic HPT (HR 1.66) to hypercalcemic HPT (HR 2.67), with minimal heterogeneity. Continuous PTH analyses showed substantial heterogeneity and were not robust in sensitivity analyses.
Conclusions
Post-transplant Persistent HPT is a consistent risk marker for mortality and adverse graft outcomes, whereas the prognostic significance of pre-transplant HPT remains to be clarified. Standardized definitions and prospective studies are needed to clarify causality and treatment effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical and Surgical Science (DIMEC), Alma Mater Studiorum-University of Bologna, Bologna, Italy.
- Nephrology, Dialysis and Kidney Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
ORCID-Profile: Daniele Vetrano, Gaetano La Manna
Zitieren
APA
Vetrano, D., Barbuto, S., Aguanno, F., Mastromauro, P., Grandinetti, V., Comai, G., La Manna, G., & Cianciolo, G. (2026). Pre-transplant and persistent post-transplant hyperparathyroidism and kidney transplant outcomes: a systematic review and meta-analysis. Clinical Kidney Journal, 19(7). https://doi.org/10.1093/ckj/sfag205
Vancouver
Vetrano D, Barbuto S, Aguanno F, Mastromauro P, Grandinetti V, Comai G, et al. Pre-transplant and persistent post-transplant hyperparathyroidism and kidney transplant outcomes: a systematic review and meta-analysis. Clinical Kidney Journal. 2026;19(7). doi:10.1093/ckj/sfag205
BibTeX
@article{Vetrano2026,
author = {Vetrano, Daniele and Barbuto, Simona and Aguanno, Francesco and Mastromauro, Paolo and Grandinetti, Valeria and Comai, Giorgia and La Manna, Gaetano and Cianciolo, Giuseppe},
title = {Pre-transplant and persistent post-transplant hyperparathyroidism and kidney transplant outcomes: a systematic review and meta-analysis},
journal = {Clinical Kidney Journal},
year = {2026},
volume = {19},
number = {7},
doi = {10.1093/ckj/sfag205}
}
EUVIMED